News

May 10, 2017 - Emerillon Capital et Sanderling Ventures joignent leurs forces afin de soutenir une nouvelle compagnie montréalaise en médecine de précision Read More

May 2, 2017 - Altor BioScience Corporation Announces FDA Fast Track Designation for Lead Candidate ALT-803 in Patients with Non-Muscle Invasive Bladder Cancer Read More

April 27, 2017 - DalCor Pharmaceuticals to Present at Bloom Burton & Co Healthcare Investor Conference 2017 Read More

April 24, 2017 - ViaCyte to Present at ARM’s 5th Annual Cell & Gene Therapy Investor Day in Boston Read More

April 20, 2017 - Automated Pharmacy Kiosk Dispenses Prescriptions like an ATM Read More

April 20, 2017 - Pharmacy Debuts Self-Serve Kiosks for VUMC Employees Read More

April 14, 2017 - Altor Bioscience and CMC Biologics Announce Agreement for Manufacture and Validation of Altor’s IL-15 Superagonist Molecule, ALT-803, for use in Phase 3 Clinical Trial Read More

March 31, 2017 - DalCor Pharmaceuticals to Present at Needham & Co. Healthcare Conference Read More

March 10, 2017 - Hill Pharmacy Announces Training Closures, Kiosk Option Read More

March 9, 2017 - ViaCyte and W. L. Gore & Associates Announce Collaborative Research Agreement to Develop Novel Implantable Delivery Technologies for Cell Therapies Read More